Latest News | Lupin Launches Generic Fenofibrate Capsules in US

New Delhi, Nov 3 (PTI) Drug firm Lupin on Wednesday said it has launched generic Fenofibrate capsules, used for the treatment of high cholesterol and triglyceride levels in the blood, in the US.

The company has launched generic version of Antara (Fenofibrate) capsules, in the strengths of 30 mg and 90 mg in the US, Lupin said in a regulatory filing.

Also Read | WhatsApp Introduces Special Diwali Stickers Pack, Here's How To Download & Send.

The product is a generic version of the Lupin Atlantis Holdings, S A Corporation's Antara capsules.

According to IQVIA MAT September 2021 data, Fenofibrate capsules had estimated annual sales of USD 7 million in the US, Lupin said.

Also Read | Cryptocurrency Investments In India: Know How Much Tax Does India Charge For Profits on Digital Currency.

"Fenofibrate Capsules are indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol, total cholesterol, triglycerides and apolipoprotein B , and to increase high-density lipoprotein cholesterol in adult patients with primary hypercholesterolemia," it added.

Shares of Lupin Ltd closed at Rs 934.75 per scrip on BSE, up 0.44 percent from its previous close.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)